دورية أكاديمية

Fecal carriage of vanB antibiotic resistance gene affects adipose tissue function under vancomycin use

التفاصيل البيبلوغرافية
العنوان: Fecal carriage of vanB antibiotic resistance gene affects adipose tissue function under vancomycin use
المؤلفون: Lars M. M. Vliex, Giang N. Le, Marina Fassarella, Dorien Reijnders, Gijs H. Goossens, Erwin G. Zoetendal, John Penders, Ellen E. Blaak
المصدر: Gut Microbes, Vol 14, Iss 1 (2022)
بيانات النشر: Taylor & Francis Group, 2022.
سنة النشر: 2022
المجموعة: LCC:Diseases of the digestive system. Gastroenterology
مصطلحات موضوعية: Antibiotic resistance, metabolic health, obesity, gut microbiome, vanB, vancomycin, Diseases of the digestive system. Gastroenterology, RC799-869
الوصف: Detrimental consequences of antibiotic treatment may include long-lasting disruption of the gut microbiota. Previous studies found no negative effects of antibiotics on metabolic health, although individualized responses were observed. Here, we aimed to investigate the subject-specific response to vancomycin use in tissue-specific insulin sensitivity by stratifying individuals based on the presence of antibiotic resistance genes (ARGs) or opportunistic pathogens (OPs) in the baseline fecal microbiota. Quantitative Polymerase Chain Reaction (qPCR) was used to detect ARGs and OPs in DNA isolated from fecal samples of 56 males with overweight/obesity (Body Mass Index: 25–35 kg/m2) and impaired glucose metabolism (fasting plasma glucose ≥5.6 mmol/L and/or 2-hour glucose 7.8–11.1 mmol/L). A two-step hyperinsulinemic-euglycemic clamp was performed to determine tissue-specific insulin sensitivity. Abdominal subcutaneous adipose tissue (AT) gene expression was assessed using Affymetrix microarray. Gut microbial composition was determined using the Human Intestinal Tract Chip (HITChip) microarray. At baseline, the vancomycin resistance gene vanB was present in 60% of our population. In individuals that were vanB-negative at baseline, AT insulin sensitivity (insulin-mediated suppression of plasma free fatty acids) improved during vancomycin use, while it decreased among vanB-positive individuals (% change post versus baseline: 14.1 ± 5.6 vs. −6.7 ± 7.5% (p = .042)). The vancomycin-induced increase in AT insulin sensitivity was accompanied by downregulation of inflammatory pathways and enrichment of extracellular matrix remodeling pathways in AT. In the vanB-positive group, well-known vanB-carrying bacteria, Enterococcus and Streptococcus, expanded in the gut microbiome. In conclusion, microbiome composition and adipose tissue biology were differentially affected by vancomycin treatment based on fecal vanB carriage.
نوع الوثيقة: article
وصف الملف: electronic resource
اللغة: English
تدمد: 19490976
1949-0984
1949-0976
العلاقة: https://doaj.org/toc/1949-0976Test; https://doaj.org/toc/1949-0984Test
DOI: 10.1080/19490976.2022.2083905
الوصول الحر: https://doaj.org/article/2bf7b039572b469e8b0527fc957a4b54Test
رقم الانضمام: edsdoj.2bf7b039572b469e8b0527fc957a4b54
قاعدة البيانات: Directory of Open Access Journals
الوصف
تدمد:19490976
19490984
DOI:10.1080/19490976.2022.2083905